Eligibility
Am I eligible for weight loss treatment?
Who is eligible for weight loss injections in the UK?
Eligibility for licensed weight-management medication is based on BMI together with weight-related health conditions, assessed individually by a prescriber. Broadly, treatment is considered at a BMI of 30 or above, or 27 or above where a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea is present. NICE advises lowering those thresholds by 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds. Meeting a threshold does not by itself mean treatment is appropriate. Contraindications, current medication and medical history are all assessed.
The BMI thresholds
BMI is the starting point rather than the decision. It is weight in kilograms divided by height in metres squared, and it is used because it is quick and reproducible, not because it is precise about any individual.
- BMI 30 or aboveGenerally considered for treatment on BMI alone.
- BMI 27 to 29.9Generally considered where a weight-related health condition is also present.
- Below 27Licensed weight-management medication is not usually appropriate.
- Adjusted thresholdsReduced by 2.5 kg/m² for South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds.
Why the thresholds are lower for some groups
Metabolic risk appears at a lower BMI in several populations. Someone from a South Asian family background can carry the cardiometabolic risk associated with a higher BMI while measuring below the standard threshold.
NICE therefore advises reducing the thresholds by 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds. In practice that means treatment may be considered from a BMI of 27.5 rather than 30, or 25 rather than 27 where a weight-related condition is present.
This is routinely omitted from eligibility information, which has the effect of under-identifying risk in precisely the groups where it develops earliest. It is worth raising directly at assessment if it applies to you.
Weight-related conditions that lower the threshold
Where BMI sits between 27 and 30, the presence of a weight-related condition is generally what brings treatment into consideration.
- Type 2 diabetes or prediabetesThe most common, and the one where weight reduction has the clearest effect.
- High blood pressureIncluding where it is already being treated.
- Obstructive sleep apnoeaFrequently improves substantially with weight reduction.
- DyslipidaemiaRaised triglycerides or low HDL cholesterol.
- Metabolic dysfunction-associated steatotic liver diseaseFat accumulation in the liver.
- Weight-related joint diseasePrincipally osteoarthritis of the knees or hips.
What rules treatment out
These are not soft preferences. Each is a contraindication or a reason for individual clinical judgement, and an assessment that identifies one will not proceed to treatment on that basis alone.
- Medullary thyroid carcinomaPersonal or family history, or Multiple Endocrine Neoplasia syndrome type 2. A firm contraindication for GLP-1 receptor agonists.
- Pregnancy, breastfeeding or planning to conceiveTreatment is not appropriate, and stopping at least a month before attempting conception is advised.
- Previous hypersensitivityTo the active ingredient or any excipient.
- History of pancreatitisRequires individual clinical assessment rather than automatic exclusion.
- Type 1 diabetes or diabetic ketoacidosisThese medicines are not a treatment for type 1 diabetes.
- Active eating disorderAppetite-suppressing medication is not appropriate and can be harmful.
- Certain gastrointestinal conditionsSevere gastroparesis or inflammatory bowel disease, assessed case by case.
What an assessment actually checks
BMI is the quickest part. The substantive work is everything around it.
A prescriber reviews your full medical history, current and recent medication, any contraindications, and how your weight relates to your wider health. Weight-management medicines are classed as high-risk, which means a prescriber cannot rely on a questionnaire alone. Your information must be independently verified, whether through direct two-way contact, access to your clinical records, or contact with your GP.
That verification requirement is a relatively recent tightening of the rules, and it is the main practical difference between a service that meets current standards and one that does not. A provider willing to dispense on a form alone is not following current guidance.
If you are not eligible
Some assessments end without treatment, and that is the process working rather than failing. Medication is one route among several, and it is not the appropriate route for everyone.
Where medication is not suitable, structured dietary and activity support remains effective, and any weight-related condition present can be treated on its own merits. If a contraindication is the reason, it is worth understanding which one. Some are permanent. Others, such as pregnancy or a planned conception, are matters of timing.
Common questions
What BMI do you need for weight loss injections in the UK?
Generally a BMI of 30 or above, or 27 or above where a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea is present. NICE advises reducing those thresholds by 2.5 kg/m² for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds.
Can I get weight loss injections with a BMI of 27?
Possibly, if a weight-related health condition is also present, type 2 diabetes, high blood pressure, sleep apnoea, dyslipidaemia or weight-related joint disease. On a BMI of 27 with no such condition, licensed weight-management medication is not usually appropriate.
Who cannot take weight loss injections?
Treatment is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN type 2, in pregnancy or breastfeeding, and with previous hypersensitivity to the active ingredient. A history of pancreatitis, type 1 diabetes, an active eating disorder and certain gastrointestinal conditions also rule it out or require individual assessment.
Does completing an assessment mean I will get treatment?
No. Assessment establishes whether treatment is clinically appropriate, which necessarily means some people are found unsuitable. A prescriber may decline on clinical grounds, and that decision is final. Any service guaranteeing treatment in advance of assessment is not conducting a real one.
Can I get treatment if I am on other medication?
Often yes, but it must be disclosed. Insulin and sulfonylureas raise the risk of low blood sugar in combination and may need dose adjustment. Delayed gastric emptying can also affect how other oral medicines are absorbed, including oral contraceptives, which need additional cover for four weeks after starting and after each dose increase.
Sources
Awaiting sign-off by a named clinician.
Last updated